NEW ORLEANS, April 06, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 21, 2018 to file lead plaintiff applications in a securities class action lawsuit against Facebook, Inc. (NasdaqGS:FB), if they purchased the Company’s shares between February 3, 2017 and March 23, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
Get Help
Facebook investors should visit us at https://www.claimsfiler.com/cases/view-facebook-inc-securities-litigation-2 or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Facebook and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company had engaged in a practice of allowing third party companies to access the personal data of millions of users without their consent for advertising and political research, in violation of its own data privacy policies; (ii) the discovery of those actions would likely result in increased scrutiny and/or fines by government regulators; and (iii) as a result of the foregoing, Facebook’s financial statements were materially false and misleading at all relevant times.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Toyota Global Sales Fall as China Demand Slumps
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Amazon Secures 200 MW Wind Power Deals in Sweden
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 



